These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 17482925)

  • 21. Transurethral radiofrequency energy collagen micro-remodeling for the treatment of female stress urinary incontinence.
    Appell RA; Juma S; Wells WG; Lenihan JP; Klimberg IW; Kanellos A; Reilley SF
    Neurourol Urodyn; 2006; 25(4):331-6. PubMed ID: 16673379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Followup of intraurethral collagen for female stress urinary incontinence.
    Herschorn S; Steele DJ; Radomski SB
    J Urol; 1996 Oct; 156(4):1305-9. PubMed ID: 8808860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds.
    Moers-Carpi M; Vogt S; Santos BM; Planas J; Vallve SR; Howell DJ
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S144-51. PubMed ID: 18086052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early results with antegrade collagen injection for post-radical prostatectomy stress urinary incontinence.
    Klutke CG; Nadler RB; Tiemann D; Andriole GL
    J Urol; 1996 Nov; 156(5):1703-6. PubMed ID: 8863575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Female stress urinary incontinence. Treatment with collagen infiltration in the urethra].
    Díaz Cabrera JA; Llerena Hoyos M; Ruiz Roldán M; Fuentes Lupiáñez C; Rodero García P; Aguayo Triano M; Burgos Rodríguez R
    Arch Esp Urol; 1997; 50(6):655-9. PubMed ID: 9412367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracorporeal magnetic innervation for the treatment of stress urinary incontinence: results of two-year follow-up.
    Hoşcan MB; Dilmen C; Perk H; Soyupek S; Armağan A; Tükel O; Ekinci M
    Urol Int; 2008; 81(2):167-72. PubMed ID: 18758214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence.
    Faerber GJ
    J Urol; 1996 Feb; 155(2):512-4. PubMed ID: 8558648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of transurethral versus periurethral collagen injection in women with intrinsic sphincter deficiency.
    Faerber GJ; Belville WD; Ohl DA; Plata A
    Tech Urol; 1998 Sep; 4(3):124-7. PubMed ID: 9800888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tension-free vaginal tape and autologous rectus fascia pubovaginal sling for the treatment of urinary stress incontinence: a medium-term follow-up.
    Sharifiaghdas F; Mortazavi N
    Med Princ Pract; 2008; 17(3):209-14. PubMed ID: 18408389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early experience with small volume periurethral polytetrafluoroethylene for female stress urinary incontinence.
    Herschorn S; Glazer AA
    J Urol; 2000 Jun; 163(6):1838-42. PubMed ID: 10799194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite premixed with lidocaine for correction of nasolabial folds.
    Marmur E; Green L; Busso M
    Dermatol Surg; 2010 Mar; 36(3):309-15. PubMed ID: 20100272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus.
    Carruthers A; Carruthers J
    Dermatol Surg; 2008 Nov; 34(11):1486-99. PubMed ID: 18811715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TVT-O for the treatment of female stress urinary incontinence: results of a prospective study after a 3-year minimum follow-up.
    Waltregny D; Gaspar Y; Reul O; Hamida W; Bonnet P; de Leval J
    Eur Urol; 2008 Feb; 53(2):401-8. PubMed ID: 17728052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsurgical, radiofrequency collagen denaturation for stress urinary incontinence: retrospective 3-year evaluation.
    Appell RA; Singh G; Klimberg IW; Graham C; Juma S; Wells WG; Kanellos A; Reilley SF
    Expert Rev Med Devices; 2007 Jul; 4(4):455-61. PubMed ID: 17605681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI.
    Marmur ES; Taylor SC; Grimes PE; Boyd CM; Porter JP; Yoo JY
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1641-5. PubMed ID: 19708876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed hypersensitivity and systemic arthralgia following transurethral collagen injection for stress urinary incontinence.
    Stothers L; Goldenberg SL
    J Urol; 1998 May; 159(5):1507-9. PubMed ID: 9554343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of injectable CaHA for the treatment of mid-face volume loss.
    Beer K; Yohn M; Cohen JL
    J Drugs Dermatol; 2008 Apr; 7(4):359-66. PubMed ID: 18459517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of in-office anesthesia during non-surgical radiofrequency collagen denaturation for stress urinary incontinence.
    Wells WG; Lenihan JP
    Curr Med Res Opin; 2007 Jun; 23(6):1279-84. PubMed ID: 17559728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current role of injectable agents for female stress urinary incontinence.
    Herschorn S
    Can J Urol; 2006 Feb; 13 Suppl 1():5-12. PubMed ID: 16526974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach.
    Ballert KN; Biggs GY; Isenalumhe A; Rosenblum N; Nitti VW
    J Urol; 2009 Feb; 181(2):679-84. PubMed ID: 19091337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.